4D Molecular Therapeutics
FDMT
FDMT
63 hedge funds and large institutions have $515M invested in 4D Molecular Therapeutics in 2021 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+7
Holders Change %
+12.5%
% of All Funds
1.11%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
11
Increased
32
Reduced
11
Closed
4
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$38.8M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$25.5M |
| 3 |
CC
3
Centiva Capital
New York
|
$7.22M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$6.2M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$9.23M |
